Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Regencell Bioscience Holdings Ltd RGC

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates... see more

NDAQ:RGC - Post Discussion

Regencell Bioscience Holdings Ltd > $RGC's own foundation and efforts to treating ADHD, ASD
View:
Post by sungrin1309 on Nov 16, 2022 4:00am

$RGC's own foundation and efforts to treating ADHD, ASD

RGC's own foundation and efforts to treating ADHD, ASD and Alzheimers

Founded in 2017, the Regencell Foundation is a nonprofit organization dedicated to providing assistance to children with ADHD and ASD, and elderly people with dementia, particularly those who are facing financial difficulties.

ADHD and ASD is a neurodevelopmental disorder characterized by impaired social interaction, challenges in verbal and non-verbal communication, and restricted and repetitive behavior. There are more than 383 million people diagnosed with ADHD and ASD globally. The foundation aims to improve the lives of children during their critical stages of development and to help them become independent to lead a normal life.

Alzheimer’s disease, the most common form of dementia, is a growing public health crisis. According to Alzheimer’s Disease International, 46.8 million people worldwide were living with dementia in 2015 and that number is expected to double every 20 years. Our mission is to reduce the burden on caregivers and their families and allow the elderly to live life with dignity.

We have supported and sponsored many charitable organizations in the past and will continue to do so in the future. For example, we have partnered with Community CareAge Foundation (CCAF) to provide dementia assessment and diagnosis, as well as financial aid.

More recently during the COVID outbreak in 2020, we have been donating masks, grocery vouchers, and hand sanitizers to The Neighborhood Advice Action Council (NAAC), a non-profit organization which lends a hand in the densely populated and deprived districts to provide consultation and counselling services to residents of all sectors.

Regencell Foundation is established by Regencell Bioscience Holding ($RGC) which is a small cap stock listed on the Nasdaq Market last year 2021. The company was founded by Mr Au Yat-Gai, whom is CEO and also a practicing Traditional Chinese Medicine practitioner himself.

Aside from works performed by the Regencell Foundation, the owner of RGC, Mr Au is also been involved in his own philanthropic project (within his own means) and aims to provided care to over 10,000 affected children with ADHD, ASD and Covid-19 and also those affected by financial difficulties. As of today, Mr Au’s project has personally helped over 150 children since the launch of this project on April 16, 22.

https://www.regencellbioscience.com/regencell-foundation/
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities